Inorganic nanoparticles incorporated with transdermal drug delivery systems

被引:0
|
作者
Nimrawi, Sukaina [1 ]
Gannett, Peter [1 ]
Kwon, Young M. [1 ]
机构
[1] Nova Southeastern Univ, Barry & Judy Silverman Coll Pharm, Dept Pharmaceut Sci, 3300 South Univ Dr, Ft Lauderdale, FL 33328 USA
关键词
Inorganic nanoparticles; transdermal; drug delivery; skin barrier; gold; silver; zinc oxide; quantum dot; GOLD NANOPARTICLES; TOPICAL DELIVERY; SKIN; METHOTREXATE; CELLS; FORMULATION; PACLITAXEL; THERAPY; LIGANDS; SURFACE;
D O I
10.1080/17425247.2024.2399710
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
IntroductionTransdermal drug delivery (TDD) is becoming more recognized as a noninvasive method particularly suitable for vulnerable populations. TDD offers an alternative to oral drug delivery, bypassing issues related to poor absorption and metabolism. However, the application of TDD is limited to a few drugs due to the skin's barrier. Various techniques, including passive methods like nanoparticles (NPs), are being explored to enhance drug permeability through the skin.Areas coveredThis review shows the benefit of incorporating inorganic NPs with TDD in improving drug delivery through the skin. Despite the potential of these techniques, there are currently only a few research studies that utilize them. This review addresses the scarcity of research incorporating inorganic NPs with TDD. It also aims to summarize both inorganic NPs and TDD in the pharmaceutical industry, highlighting the advantages of incorporating these novel drug delivery systems with each other.Expert opinionGiven the potential benefits of incorporating inorganic NPs into TDD systems, there is a need for increased research and attention in this area. The review encourages scientists to address the existing research gap and explore the advantages of combining these innovative drug delivery systems to advance the field.
引用
下载
收藏
页数:14
相关论文
共 50 条
  • [1] TRANSDERMAL DRUG DELIVERY SYSTEMS
    NIEDNER, R
    HAUTARZT, 1988, 39 (12): : 761 - 766
  • [2] TRANSDERMAL DRUG DELIVERY SYSTEMS
    BHARGAVA, HN
    OZA, BJ
    ROJANASKUL, Y
    DRUG & COSMETIC INDUSTRY, 1984, 134 (01): : 52 - &
  • [3] EFFECT OF NANOPARTICLES ON TRANSDERMAL DRUG DELIVERY
    CAPPEL, MJ
    KREUTER, J
    JOURNAL OF MICROENCAPSULATION, 1991, 8 (03) : 369 - 374
  • [4] Drug-inorganic-polymer nanohybrid for transdermal delivery
    Kim, Myung Hun
    Park, Dae-Hwan
    Yang, Jae-Hun
    Choy, Young Bin
    Choy, Jin-Ho
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 444 (1-2) : 120 - 127
  • [5] RECENT TRENDS IN DRUG DELIVERY SYSTEMS - TRANSDERMAL DRUG DELIVERY
    MISHRA, B
    PANDIT, JK
    BHATTACHARYA, SK
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 1990, 28 (11) : 1001 - 1007
  • [6] DRUG DELIVERY SYSTEMS .6. TRANSDERMAL DRUG DELIVERY
    RANADE, VV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (05): : 401 - 418
  • [7] Microemulsions as Transdermal Drug Delivery Systems
    El Maghraby, Gamal M.
    CURRENT NANOSCIENCE, 2012, 8 (04) : 504 - 511
  • [8] DEVELOPMENT OF TRANSDERMAL DRUG DELIVERY SYSTEMS
    CHIEN, YW
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (4-5) : 589 - 651
  • [9] Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
    Carter, Prerana
    Narasimhan, Balaji
    Wang, Qun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 555 : 49 - 62
  • [10] Inorganic nanoparticles in drug delivery Preface
    Mattoussi, Hedi
    Rotello, Vincent M.
    ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (05) : 605 - 606